Amarin Corp. Plc (AMRN)
14.10
-1.42
(-9.15%)
USD |
NASDAQ |
Feb 25, 10:35
Amarin Research and Development Expense (Quarterly) : 3.320M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Trinity Biotech Plc | 0.8134M |
| Alkermes Plc | 80.34M |
| Jazz Pharmaceuticals Plc | 198.20M |
| Biodexa Pharmaceuticals Plc | -- |
| Evaxion AS | 2.158M |